Jones, R N <br/><br/>
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates.  [electronic resource] 

 -  Diagnostic microbiology and infectious disease  Apr 1995 
 - 209-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0732-8893 
<br/><br/><label>Standard No.: </label>10.1016/0732-8893(94)00061-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Infective Agents--pharmacology<br/>Ciprofloxacin--pharmacology<br/>Drug Resistance, Microbial<br/>Fleroxacin--pharmacology<br/>Fluoroquinolones<br/>Microbial Sensitivity Tests--methods<br/>Quinolones--pharmacology<br/>Sensitivity and Specificity